The Transcription Factor SOX18 Inhibitor Small Molecule 4 Is a Potential Treatment of Cancer‐Induced Lymphatic Metastasis and Lymphangiosarcoma
ABSTRACT Background Malignant tumors release growth factors, promoting lymphangiogenesis in primary tumors and draining sentinel lymph nodes, ultimately facilitating lymph node metastasis. As a malignant lymphatic tumor entity, lymphangiosarcomas are characterized by low survival rates and limited t...
Saved in:
Main Authors: | Katja K. Koll, Martin M. Zimmermann, Patrick A. Will, Ulrich Kneser, Christoph Hirche |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.70110 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Abdominal lymphatic malformations in children: case series
by: Carmine Noviello, et al.
Published: (2025-01-01) -
A Proposed Role for Lymphatic Supermicrosurgery in the Management of Alzheimer's Disease: A Primer for Reconstructive Microsurgeons
by: Joon Pio Hong, et al. -
Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma
by: Wubuli Reziwanguli, et al.
Published: (2025-02-01) -
Prognosis of premenopausal women with low-risk endometrial cancer but elevated CA125 levels
by: Jeong Min Song, et al.
Published: (2025-01-01) -
Gross recurrent laryngeal nerve invasion by extranodal extension in thyroid carcinoma
by: Xin Li, et al.
Published: (2025-01-01)